After some people started using Ivermectin as a treatment for Covid-19 symptoms, the media and government engaged in a vicious campaign to discredit the treatment and attack people who used it.  Now, research funded by Bill and Melinda Gates found that Ivermectin causes no significant negative side effects.  The Gateway Pundit Reports

“MedinCell tested ivermectin taken daily in oral form to simulate the continuous release of the active substance by a long-acting injectable. After completion, the study confirms the safety of ivermectin up to a dose of 100 μg / kg / day in continuous administration over 1 month in healthy volunteers. No significant difference was observed between the treated volunteers and the placebo volunteers in the three cohorts studied successively (daily doses of 50 μg / kg, 75 μg / kg and 100 μg / kg respectively).

The pharmacokinetic data of the three cohorts shows a limited peak circulating plasma concentration in the first 12 hours (Cmax between 25-60 ng / mL) and the rapid achievement of a stationary regime and a regular plasma concentration of between approximately 10 and 30 ng / mL for 28 days, depending on the dose administered. These preliminary results are considered positive and live up to Company expectations based on the data in the literature. The dose-response relationship has not yet been established.”

After prominent figures such as Aaron Rodgers and Joe Rogan admitted to using Ivermectin as a treatment for Covid-19, the media immediately began attacking them.  Despite this, Dr. Pierre Kory, President and Founder of the Front Line COVID-19 Critical Care Alliance said that over 200 members of Congress were treated with Ivermectin during the Covid pandemic.


Join The Conversation. Leave a Comment.

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.